Conger Daniel E 4
4 · Semler Scientific, Inc. · Filed Jun 14, 2019
Insider Transaction Report
Form 4
Conger Daniel E
Vice President of Finance
Transactions
- Sale
Common Stock
2019-06-14$41.13/sh−4,500$185,076→ 0 total - Exercise/Conversion
Common Stock
2019-06-14$2.10/sh+2,500$5,250→ 2,500 total - Exercise/Conversion
Common Stock
2019-06-14$2.59/sh+2,000$5,180→ 4,500 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-06-14−2,500→ 0 totalExercise: $2.10Exp: 2024-11-08→ Common Stock (2,500 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2019-06-14−2,000→ 3,000 totalExercise: $2.59Exp: 2025-12-31→ Common Stock (2,000 underlying)
Footnotes (3)
- [F1]The price reported is a weighted average price. The shares were sold at prices ranging from $41.00 to $42.00. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F2]These options were granted pursuant to the Issuer's 2014 Stock Incentive Plan and are fully vested.
- [F3]These options were granted pursuant to the Issuer's 2014 Stock Incentive Plan and are subject to monthly vesting over four years (1/48 per month) such that they will be vested in full on the four-year anniversary of the December 31, 2015 grant date.